Raymond James & Associates’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,336	Closed	-$296K	–	3813
2023 Q1	$296K	Sell	11,336 -3,237	-22%	-$84.5K	﹤0.01%	3225
2022 Q4	$400K	Sell	14,573 -110,452	-88%	-$3.03M	﹤0.01%	3025
2022 Q3	$3.01M	Buy	+125,025	New	+$3.01M	﹤0.01%	1719